BIOM-87. SODIUM (23NA) MRI AND CHEMICAL EXCHANGE SATURATION TRANSFER (CEST) IMAGING IN TYPICALLY DEVELOPING CHILDREN AND IN PEDIATRIC BRAIN TUMORS

生物分子-87. 钠(23Na)磁共振成像和化学交换饱和转移(CEST)成像在正常发育儿童和儿童脑肿瘤中的应用

阅读:1

Abstract

In contrast to conventional (1)H MRI, which primarily reveals water molecule distribution, with only indirect association with the physico-chemical microenvironment, (23)Na (sodium) MRI and chemical exchange saturation transfer (CEST) have a more direct physiological interpretation, reflecting biochemical and physiologic changes in the cells of tissues, e.g. cell integrity and tissue viability allowing for direct assessment of cell membrane sodium ion channel function. Sodium concentrations are measurable by (23)Na MRI and mobile proteins are measured with CEST [Amide Proton Transfer (APT) signal intensity]; when these are elevated, they have shown to be markers of tumors and proliferation. In this study, we acquired (23)Na MRIs and APT in children with central nervous system (CNS) tumors and typically-developing (TD) pediatric controls. Sodium concentrations and APT signal were analyzed in regions of normal brain (brainstem, cerebellum, cerebral cortical grey matter, cerebral white matter, basal ganglia, hippocampus, thalamus) of TD controls and in pediatric brain tumors. The sodium concentration and APT in tumors were compared to homologous regions of the brains of TD controls. We hypothesized that sodium concentrations and APT signal will be greater in tumors compared to healthy brain in TD controls. We also analyzed the repeatability of subjects that received (23)Na MRIs and CEST at two timepoints. Preliminary data demonstrates elevated sodium concentrations and APT signal in pediatric brain tumors (n = 5) compared to TD controls (n = 3). There was repeatability at two timepoints with consistent sodium concentrations and APT signal in TD controls (n = 3) and in pediatric brain tumors (n = 4). In conclusion, performing (23)Na-MRI and CEST is feasible in pediatric patients with brain tumors. Future work will help answer the complex questions in monitoring treatment of pediatric patients with brain tumors: is there residual or recurrent tumor and differentiating tumor progression versus pseudoprogression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。